## 

## 

|**Trustees**|MrACCaton OBE||
|---|---|---|
||MrSBMoodey||
||Mr A Phillips||
||MsE L Pintado||
||MrAWPollitt||
||Prof Andrew Grace|(Appointed 24 July 2023)|
||Prof Andrew Coats|(Appointed 3 April 2023)|
|**Secretary**|MsS Callaghan||
|**Charity number**|1116918||
|**Charity number (Scotland)**|SC042984||
|**Company number**|05935975||
|**Registered office**|Bankside 300||
||Peachman Way||
||Broadland Business Park||
||Norwich||
||Norfolk||
||NR7 0LB||
|**Auditor**|Azets Audit Services||
||Westpoint||
||Lynch Wood||
||Peterborough||
||Cambridgeshire||
||United Kingdom||
||PE26FZ||
|**Bankers**|Santander UK PLC||
||2 Triton Square||
||Regent's Place||
||London||
||United Kingdom||
||BankofIreland||
||12The High Street||
||KildareTown||
||CO. Kildare||






## 

## 

||**Page**|
|---|---|
|Trustees report|1 - 4|
|StatementofTrustees responsibilities|5|
|Independent auditor's report|6-8|
|Statementoffinancial activities|9|
|Balance sheet|10|
|Statementofcash flows|11|
|Notestothe financial statements|12- 19|





## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 




## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 


## 


## 



## 

## 

|**Unrestricted Unrestricted**<br>**funds**<br>**funds**<br>**general designated**<br>**2023**<br>**2023**<br>**Notes**<br>£<br>£<br>**Income from:**<br>Donations and legacies<br>**3**<br>441,958<br>Other trading activities<br>**4**<br>257,635<br>Investments<br>**5**<br>165,516<br>**Total income**<br>865,109<br>**Ex~enditure on:**<br>Raising funds<br>**6**<br>273,638<br>Charitable activities<br>**7**<br>437,049<br>160,798<br>**Total expenditure**<br>710,687<br>160,798<br>**Net incoming resources**<br>**before transfers**<br>154,422<br>(160,798)<br>Gross transfers between<br>funds<br>132,992<br>(132,992)<br>**Net income for the year/**<br>**Net incoming resources**<br>287,414<br>(293,790)<br>**Other recognised gains and losses**<br>Other gains or losses<br>**10**<br>**Net movementinfunds**<br>287,414<br>(293,790)<br>Fundbalances at 1 January<br>2023<br>2,467,516<br>607,795<br>**Fund balances at31**<br>**December 2023**<br>2,754,930<br>314,005|**Total Unrestricted Unrestricted**<br>**funds**<br>**funds**<br>**general designated**<br>**2023**<br>**2022**<br>**2022**<br>£<br>£<br>£<br>441,958<br>475,043<br>257,635<br>290,936<br>165,516<br>31,955<br>865,109<br>797,934<br>273,638<br>147,965<br>597,847<br>530,866<br>871,485<br>678,831<br>(6,376)<br>119,103<br>(607,795)<br>607,795<br>(6,376)<br>(488,692)<br>607,795<br>326<br>(6,376)<br>(488,366)<br>607,795<br>3,075,311<br>2,955,882<br>3,068,935<br>2,467,516<br>607,795|**Total**<br>**2022**<br>£<br>475,043<br>290,936<br>31,955|
|---|---|---|
|||797,934|
|||147,965|
|||530,866<br>678,831<br>119,103<br>119,103<br>326<br>119,429<br>2,955,882<br>3,075,311|





## 

## 

## 

|**Notes**<br>**Current assets**<br>Debtors<br>**11**<br>Cash at bankandinhand<br>**Creditors: amounts falling due within**<br>**one year**<br>**12**<br>Net current assets<br>**Income funds**<br>Unrestricted funds<br>Designated funds<br>**13**<br>General unrestricted funds|**2023**<br>£<br>28,445<br>3,424,056<br>3,452,501<br>(383,566)<br>314,005<br>2,754,930|<br>£<br>3,068,935<br>3,068,935<br>3,068,935|**2022**<br>£<br>64,515<br>3,476,623<br>3,541,138<br>(465,827)<br>607,795<br>2,467,516|<br>£<br>3,075,311|
|---|---|---|---|---|
|||||3,075,311|
|||||3,075,311|



## 



## 

## 

|**Cash flows from operating activities**<br>Cash (absorbed by)/generated from<br>operations<br>**Notes**<br>**16**<br>**Investing activities**<br>Investment income received<br>**Net cash generated from investing**<br>**activities**<br>**Net cash usedinfinancing activities**<br>**Net (decrease)/increaseincash and cash**<br>**equivalents**<br>Cash and cash equivalents at beginning of year<br>**Cash and cash equivalents at end of year**|**2023**<br>£<br>165,516<br>£<br>(218,083)<br>165,516<br>(52,567)<br>3,476,623<br>3,424,056|**2022**<br>£<br>31,955<br>£<br>494,702<br>31,955<br>526,657<br>2,949,966<br>3,476,623|
|---|---|---|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

||**Unrestricted**|Unrestricted|
|---|---|---|
||**funds**|funds|
||**general**|general|
||**2023**|2022|
||£|£|
|Donations and gifts|441,958|475,043|
|**Donations and gifts**|||
|General donations|40,519|7,055|
|Pledge program donations|401,439|467,988|
||441,958|475,043|





## 

## 

## 

|**4**<br>**Other trading activities**<br>**Unrestricted**<br>**funds**<br>**general**<br>**2023**<br>£<br>Lottery activities<br>257,635<br>**5**<br>**Investments**<br>**Unrestricted**<br>**funds**<br>**general**<br>**2023**<br>£<br>Interest receivable<br>165,516<br>**6**<br>**Raising funds**<br>**Unrestricted**<br>**funds**<br>**general**<br>**2023**<br>£<br>Fundraising and publicity<br>Seeking donations, grants and legacies<br>22,011<br>Other fundraising costs<br>251,627<br>Fundraising and publicity<br>273,638<br>273,638|Unrestricted<br> <br>funds<br> <br>general<br> <br>2022<br> <br>£<br> <br>290,936<br> Unrestricted<br>funds<br> <br>general<br> <br>2022<br> <br>£<br>31,955<br> Unrestricted<br>funds<br> <br>general<br>2022<br> <br>£<br>23,024<br>124,941<br>147,965<br>147,965|
|---|---|





## 

## 

## 

|Awareness costs<br>Research costs<br>Shareofgovernance costs (see note 8)<br>**Analysisbyfund**<br>Unrestricted funds - general<br>Unrestricted funds - designated|**2023**<br>£<br>13,347<br>548,472<br>561,819<br>36,028<br>597,847|**2022**<br>£<br>23,515<br>479,434<br>502,949<br>27,917<br>530,866<br>530,866<br>530,866|
|---|---|---|
||437,049<br>160,798<br>597,847||



|**Support and governance costs**<br>Auditor fees<br>Legal and professional<br>Charitable activities|**2023**<br>2022<br>**Governance**Governance<br>**costs**<br>costs<br>£<br>£<br>18,900<br>18,900<br>17,128<br>9,017<br>36,028<br>27,917<br>36,028<br>27,917|**2023**<br>2022<br>**Governance**Governance<br>**costs**<br>costs<br>£<br>£<br>18,900<br>18,900<br>17,128<br>9,017<br>36,028<br>27,917<br>36,028<br>27,917|**2023**<br>2022<br>**Governance**Governance<br>**costs**<br>costs<br>£<br>£<br>18,900<br>18,900<br>17,128<br>9,017<br>36,028<br>27,917<br>36,028<br>27,917|
|---|---|---|---|
||||27,917<br>27,917|
|||36,028||



## 

## 



## 

## 

|**1 0**<br>**Other gains or losses**<br>Foreign exchange gains<br>**11**<br>**Debtors**<br>**Amounts falling due within one year:**<br>Other debtors<br>Prepayments and accrued income<br>**12**<br>**Creditors: amounts falling due within one year**<br>Trade creditors<br>Amount owed to parent undertaking<br>Accruals and deferred income|**2023**<br>£<br>17,481<br>10,964<br>28,445<br>Unrestricted<br>funds<br>general<br>2022<br>£<br>(326)<br>**2022**<br>£<br>54,866<br>9,649<br>64,515<br>**2023**<br>**2022**<br>£<br>£<br>91,164<br>26,022<br>266,380<br>383,566<br>4,143<br>94,269<br>367,415<br>465,827|
|---|---|





## 

## 

## 

|**Balance at**<br>**1 January 2022**<br>£<br>Collaborator contracts<br>Funding committed for<br>parent company|**Transfers**<br>**Balance at**<br>**1 January 2023**<br>£<br>£<br>79,529<br>79,529<br>528,266<br>528,266<br>607,795<br>607,795|**Resources**<br>**expended**<br>£<br>(160,798)<br>(160,798)|**Transfers**<br>**Balance at**<br>**31December**<br>**2023**<br>£<br>£<br>(79,529)<br>(53,463)<br>314,005<br>(132,992)<br>314,005|**Transfers**<br>**Balance at**<br>**31December**<br>**2023**<br>£<br>£<br>(79,529)<br>(53,463)<br>314,005<br>(132,992)<br>314,005|
|---|---|---|---|---|
|||||314,005|



## 

|**Unrestricted Designated**<br>**funds**<br>**funds**<br>**2023**<br>**2023**<br>£<br>£<br>Fund balances at31<br>December 2023 are<br>representedby:<br>Current assets/(liabilities)<br>2,754,930<br>314,005<br>2,754,930<br>314,005|**Total**<br>**2023**<br>£<br>3,068,935<br>3,068,935<br>Unrestricted<br>Designated<br>funds<br>funds<br>2022<br>2022<br>£<br>£<br>2,467,516<br>607,795<br>2,467,516<br>607,795|Total<br>2022<br>£<br>3,075,311|
|---|---|---|
|||3,075,311|



## 

|Balance duetoThe Heart Research Limited,<br>the ultimate parent company.<br>**Amounts owedto**<br>**parties**<br>**2023**<br>£<br>26,022<br>26,022|**related**<br>**2022**<br>£<br>94,269|
|---|---|
||94,269|





## 

## 

|**16**<br>**Cash generated from operations**<br>(Deficit)/surpus for the year<br>Adjustments for:<br>Investment income recognisedinstatement of financial activities<br>Foreign exchange differences<br>Movementsinworking capital:<br>Decrease/(increase)indebtors<br>(Decrease)/increaseincreditors<br>**Cash (absorbed by)/generated from operations**<br>**2023**<br>£<br>(6,376)<br>(165,516)<br>36,070<br>(82,261)<br>(218,083)|**2022**<br>£<br>119,103<br>(31,955)<br>326<br>(24,945)<br>432,173<br>494,702|
|---|---|



## 

## 

